Somnigroup (SGI) Q3 2025 earnings review
Synergies Drive Record Quarter & Turnaround; Capital Returns Resuming in Q1'26
Somnigroup delivered a significant Q3 inflection, demonstrating that the Mattress Firm (MFRM) acquisition is paying off faster than anticipated. While reported revenue growth of 63% was driven by the MFRM consolidation, the key highlight was the reversal in underlying trends: aggregate like-for-like sales grew 5% after two quarters of declines. This operational turnaround, powered by accelerating sales synergies and strong product performance, drove a sharp rebound in profitability, with adjusted EPS flipping from a 16% decline in Q2 to 16% growth in Q3. Bolstered by record cash flow and rapid deleveraging, management raised full-year guidance and signaled high confidence by announcing plans to reinstate capital returns in Q1 2026.
๐ Bull Case
Sales synergies are materializing faster than planned. The company now expects Tempur Sealy brands to represent a mid-50% share of MFRM sales in 2025, contributing $60 million in EBITDA benefit this year alone.
After a soft first half, the core business has turned a corner. Same-store sales at Mattress Firm grew 5% and like-for-like sales at Tempur Sealy North America also grew 5%, indicating successful product launches and marketing efforts are gaining traction.
Management announced plans to begin allocating ~50% of free cash flow to dividends and share repurchases in Q1 2026, a strong signal of confidence in the sustainability of its cash generation and deleveraging progress.
๐ป Bear Case
The company's outperformance is occurring while the U.S. bedding market remains at 'trough levels'. A broader macroeconomic downturn could stall consumer spending on big-ticket items and threaten the recovery.
While declining rapidly, the leverage ratio of 3.3x remains above the company's 2-3x target range. This elevates financial risk and constrains strategic flexibility until the target is comfortably achieved.
โ๏ธ Verdict: ๐ข
Bullish. The strong operational execution and faster-than-expected synergy capture are compelling. The sharp reversal in underlying sales and profitability, coupled with record cash flow, demonstrates the power of the combined entity. The clear signal on resuming capital returns underscores management's high degree of confidence in the outlook.
Key Themes
Mattress Firm Sales Synergies Accelerating
The primary driver this quarter was the rapid progress in capturing sales synergies. Management increased its target for Tempur Sealy (TS) brands' share of MFRM sales from 'below 50%' to 'mid-50%' for 2025. This balance-of-share gain is now expected to contribute $60 million of adjusted EBITDA benefit in 2025, with an incremental $40 million in 2026, keeping the company on track for its $100 million run-rate sales synergy goal. The new 'Sleep Easy' ad campaign is also performing well, driving traffic and conversion.
Core Business Rebounds Sharply
After a challenging first half, the underlying business has inflected positively. In North America, Tempur Sealy's like-for-like sales grew 5%, reversing from a 2% decline in Q2. Mattress Firm's same-store sales also grew 5%, a significant acceleration from a 1% decline last quarter. This indicates that the new Sealy Posturepedic products and retooled advertising are successfully driving demand and market share gains despite a flat industry backdrop.
International Segment Remains a Growth Engine
The international business continues to be a standout performer, delivering 11% reported sales growth (7% constant currency). This marks the 10th consecutive quarter of strong growth, driven by the refreshed Tempur product line, expanded distribution, and effective local execution in a challenging global environment. This provides valuable diversification and a consistent source of growth.
Macro Environment Remains a Headwind
Management continues to describe the U.S. bedding market as being at 'trough levels' and 'basically flat'. The company's strong results are driven by market share gains and synergies, not an industry recovery. The guidance for the U.S. bedding industry to be down low to mid-single digits for the full year underscores the risk that a weakening consumer could slow momentum.
Data Contradiction: Potential Margin Pressure from Product Mix
While consolidated margins were strong, the narrative focuses heavily on the success of the new Sealy Posturepedic line. As noted in the Q2 call, strong performance of the lower-margin Sealy brand relative to the premium Tempur-Pedic brand could create a 'slight headwind' to gross margin percentage. This remains a key point to monitor to ensure profitability quality is maintained as the company gains share.
Capital Allocation Shift Signals Confidence
The plan to reinstate shareholder returns in Q1 2026, allocating approximately 50% of free cash flow, is a significant positive development. This reflects strong confidence from management in their ability to continue generating robust cash flow and comfortably reach their target leverage range of 2-3x early next year. It marks a shift from a post-acquisition focus on deleveraging to a more balanced capital allocation policy.
Innovation in Smart Bedding
The company is cementing its leadership in sleep technology through a strategic $25 million investment for a 15.6% stake in Fullpower, the creator of Sleeptracker-AI. This includes an extension of exclusive rights through 2036, securing a key technology partner. The MFRM acquisition helps accelerate this strategy by providing a large, controlled channel to deploy and scale new smart bedding innovations.
Other KPIs
Deleveraging is occurring faster than expected. The leverage ratio declined from 3.56x in Q2 to 3.3x this quarter, driven by record operating cash flow of $408 million. Management now expects to return to their target 2-3x range early in 2026, which is unlocking the ability to resume capital returns.
The company generated a record $360 million in free cash flow during the quarter. This powerful cash generation, even in a soft market, demonstrates the financial strength of the combined business model and is the key enabler for the rapid debt paydown.
Guidance
Accelerating. Guidance was raised from a midpoint of $2.55 to $2.675. This implies Q4 adjusted EPS of ~$0.71, representing YoY growth of ~17.5%. This indicates continued strong performance and operational momentum into year-end, following the 16% growth in Q3.
The guidance revision was driven by an improved industry outlook (now down low-to-mid single digits vs. mid-single digits) and faster synergy capture. The implied Q4 guidance calls for continued LFL sales growth across business units: Tempur Sealy (mid-to-high single digits) and Mattress Firm (low-single digits).
